HARROW, INC. — Director's Dealing 2008

Jul 1, 2008

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TRANSDEL PHARMACEUTICALS INC (TDLP.OB)
CIK: 0001360214
Period of Report: 2008-06-27

Reporting Person: THORNLEY ANTHONY S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2008-06-27	Common stock	P	4200	$1.74	Acquired	54200	Direct

Footnotes

F1: This transaction was executed in multiple trades through a trade order executed by a broker-dealer at prices ranging from
$1.73 to $1.75. The price reported in this column reflects the weighted average purchase price. For all transactions
reported on this Form 4 utilizing a weighted average price, the reporting person will provide upon request to the SEC staff,
the issuer or a security holder of the issuer full information regarding the number of shares purchased at each price.